About this trial
This study aims to investigate the effect of femoral triangle block combined with popliteal plexus block and distal IPACK block on postoperative pain after total knee arthroplasty (TKA)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing total knee arthroplasty under spinal anesthesia
American Society of Anesthesiologists (ASA) status I-III
Patients who give informed consent
Disqualifiers
Patients unable to cooperate
Kidney disease with GFR < 50 ml/min
Daily opioid consumption > 1 month
Allergy to local anesthetics
Trial design
Parallel
Treatments tested in this trial
femoral triangle block and popliteal plexus block
DeviceSingle dose bolus, 10 ml 5% bupivacaine will be used for FTB, 10 ml 5% bupivacaine will be used for PPB
Femoral triangle block and distal iPACK
DeviceSingle dose bolus, 10 ml 5% bupivacaine will be used for FTB, 10 ml 5% bupivacaine will be used for distal iPACK
Treatment groups
Trial outcomes
Primary outcomes
Opioid consumption
Total opioid consumption in each group, A, B until 24 hours postoperative.
Secondary outcomes
NRS scores
Numerical Rating Scale (NRS) scores (Range 0-10, 0=no pain, 10=the worse pain ever)
Range of knee motion
Degrees of flexion
Patient mobilization
Patient reporting time of first standing to the side of the bed and time up and go test 2 days
Post-block Maximum Voluntary Isometric Contraction (MVIC) by knee extension, calculated as a percentage of the Pre-block baseline value
Both MVIC test are assessed preoperative, using a handheld dynamometer
Sponsors and contacts
Click on the lead sponsor to view all of their trials.